Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung

Journal of Thoracic Oncology

Volumn 3, Issue 7, 2008, Pages 698-703

  Maeshima, Akiko Miyagi ^a   Tochigi, Naobumi ^a   Tsuta, Koji ^a   Asamura, Hisao ^b   Matsuno, Yoshihiro ^c  

^a NATIONAL CANCER CENTER HOSPITAL   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c HOKKAIDO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adenocarcinoma; Histology; Lung; Smoking

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD VESSEL PERMEABILITY; CANCER INCIDENCE; CANCER INVASION; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HISTOLOGY; HUMAN; INVASIVE ADENOCARCINOMA; INVASIVE CARCINOMA; LUNG; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; NECROSIS; PATHOLOGY; PERIPHERAL SMALL LUNG ADENOCARCINOMA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; SCAR; SMOKING; SOLID TUMOR; SURVIVAL RATE; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME; ADENOCARCINOMA; LUNG TUMOR; MIDDLE AGED; MORTALITY;

ADENOCARCINOMA; ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; SMOKING; SURVIVAL RATE;

EID: 50349102871     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31817c60ae     Document Type: Article

References (26)

1. Barsky SH, Cameron R, Osann KE, Tomita D, Holmes EC. Rising incidence of bronchioloalveolar lung carcinoma and its unique clinico-pathologic features. Cancer 1994;73:1163-1170.
2. Travis WD, Travis LB, Devesa SS. Lung cancer. Cancer 1995;75: 191-202.
3. International Agency for Research on Cancer. "IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking, vol 83." Lyon, France: World Health Organization, IARC, 2002. Pp. 199-308.
4. Celikoglu SI, Aykan TB, Karayel T, Demirci S, Göksel FM. Frequency of distribution according to histological types of lung cancer in the tracheobronchial tree. Respiration 1986;49:152-156.
5. Garland L, Beier R, Coulson W, Heald JH, Stein RL. The apparent sites of origin of carcinomas of the lung. Radiology 1962;78:1-11.
6. Lulu D, Lawson L. Carcinoma of the lung. Arch Surg 1964;88:213-217.
7. Huhti E, Saloheimo M, Sutinen S, Reinilä A. Does the location of lung cancer affect its prognosis? Eur J Respir Dis 1983;64:460-465.
8. Byers TE, Vena JE, Rzepka TF. Predilection of lung cancer for the upper lobes: an epidemiologic inquiry. J Natl Canc Inst 1984;72:1271-1275.
9. Lee BW, Wain JC, Kelsey KT, Wiencke JK, Christiani DC. Association of cigarette smoking and asbestos exposure with location and histology of lung cancer. Am J Respir Crit Care Med 1998;157:748-755.
10. Sobue T, Suzuki T, Fujimoto I, Doi O, Tateishi R, Sato T. Prognostic factors for surgically treated lung adenocarcinoma patients, with special reference to smoking habit. Jpn J Cancer Res 1991;82:33-39.
11. Nordquist LT, Simon GR, Cantor A, Alberts WM, Bepler G. Improved survival in never-smokers vs current smokers with primary adenocarci-noma of the lung. Chest 2004;126:347-351.
12. Yoshino I, Kawano D, Oba T, Yamazaki K, Kometani T, Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg 2006;81:1189-1193.
13. Shiba M, Kohno H, Kakizawa K, et al. Ki-67 immunostaining and other prognostic factors including tobacco smoking in patients with resected nonsmall cell lung carcinoma. Cancer 2000;89:1457-1465.
14. Suzuki T, Sobue T, Fujimoto I, Doi O, Tateishi R. Association of adenocarcinoma of the lung with cigarette smoking by grade of differentiation and subtype. Cancer Res 1990;50:444-447.
15. Morita T, Urano Y. An autopsy study of lung cancer with special reference to the relationship between cigarette smoking and histological differentiation of adenocarcinoma and squamous cell carcinoma. Jpn J Clin Oncol 1989;19:94-101.
16. Shimosato Y, Hashimoto T, Kodama T, et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers. Am J Surg Pathol 1980;4:365-373.
17. Clayton F. The spectrum and significance of bronchioloalveolar carcinomas. Pathol Annu 1988;23:361-394.
18. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995;75: 2844-2852.
19. Sobin LH, Wittekind C. International Union Against Cancer: TNM classification of malignant tumours, 6th Ed. New York: Wiley-Liss, 2002.
20. Maeshima AM, Niki T, Maeshima A, Yamada T, Kondo H, Matsuno Y. Modified scar grade: prognostic indicator of peripheral lung adenocar-cinoma 30 mm or less. Cancer 2002;95:2546-2554.
21. Westra WH, Slebos RJC, Offerhaus GJA, et al. K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung. Cancer 1993;72:432-438.
22. Tam IY, Chung LP, Suen WS, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cncer Res 2005;12:1647-1653.
23. Le Calvez F, Mukeria A, Hunt JD, et al. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res 2005;65:5076-5083.
24. Westra WH, Offerhaus GJ, Goodman SN, et al. Overexpression of the p53 tumor suppressor gene product in primary lung adenocarcinomas is associated with cigarette smoking. Am J Surg Pathol 1993;17:213-220.
25. Yohena T, Yoshino I, Takenaka T, et al. Relationship between the loss of heterozygosity and tobacco smoking in pulmonary adenocarcinoma. Oncol Res 2007;16:333-339.
26. Hashimoto T, Tokuchi Y, Hayashi M, et al. Different subtypes of human lung adenocarcinoma caused by different etiological factors. Evidence from p53 mutational spectra. Am J Pathol 2000;157:2133-2141.